PHI with Primary biliary cholangitis (PBC)
How does this condition affect your private health insurance?
Primäre biliäre Cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic autoimmune liver disease. It targets and progressively destroys the small bile ducts within the liver, impeding bile flow (cholestasis). This leads to the accumulation of toxic substances, causing inflammation, scarring (fibrosis), and eventually cirrhosis. Initial symptoms often include debilitating fatigue and pruritus (itching). As the disease advances, jaundice, malabsorption, and signs of liver failure can emerge. While there is no cure, early diagnosis and treatment with ursodeoxycholic acid can significantly slow disease progression. Liver transplantation is a treatment option for end-stage disease.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Insidious onset, symptoms developing subtly over months to years before diagnosis.
Duration of Illness (Lifetime)
Chronic and progressive, typically lasting for many years or decades throughout the patient's lifetime.
Cost of Treatment (Initial)
High (initial diagnostic tests including blood work, imaging, potential liver biopsy; initial medication costs for ursodeoxycholic acid).
Cost of Treatment (Lifetime)
Very high (lifelong medication, regular monitoring, management of numerous complications, potential for extremely expensive liver transplant).
Mortality Rate
Moderate to high if untreated or if significant complications like liver failure develop despite treatment. Risk is reduced with effective management but remains elevated compared to the general population.
Risk of Secondary Damages
High (common complications include severe fatigue, debilitating pruritus, osteoporosis, sicca syndrome, hyperlipidemia, malabsorption, portal hypertension, liver failure, and increased risk of hepatocellular carcinoma or cholangiocarcinoma).
Probability of Full Recovery
Very low (PBC is a chronic, progressive autoimmune disease with no known cure; treatment focuses on halting or slowing disease progression).
Underlying Disease Risk
Moderate to high (PBC is frequently associated with other autoimmune conditions, such as Sjögren's syndrome, autoimmune thyroiditis, rheumatoid arthritis, celiac disease, or Raynaud's phenomenon).